RF ablation single electrode market seen reaching $1.72 billion by 2030

The radiofrequency ablation single electrode market is projected to grow from $1.08 billion in 2025 to $1.72 billion by 2030, driven by demand for minimally invasive procedures, chronic pain treatments and better healthcare infrastructure. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through the forecast period.

Why it matters: - RF ablation single electrode devices sit at the center of minimally invasive treatment for cardiac, pain management and some cosmetic procedures. - The market's growth signals wider adoption of targeted energy-based treatments that can reduce recovery time and collateral tissue damage. - Rising procedure volumes and healthcare investment could expand access to these devices across more hospitals and outpatient settings.

What happened: - The Business Research Company projected the global RF ablation single electrode market will rise from $1.08 billion in 2025 to $1.19 billion in 2026. - The market is forecast to reach $1.72 billion by 2030, implying a 9.8% CAGR from 2026 to 2030. - The company released its Radiofrequency (RF) Ablation Single Electrode Global Market Report 2026 covering market size, trends and forecasts through 2035. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report also adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables.

The details: - The report said the market's 2025-2026 growth reflects a 9.5% CAGR in the historical period. - Drivers included more cardiac arrhythmia cases, early use of open surgical ablation, limited availability of minimally invasive RF systems, better catheter-based electrode design and more hospital interventional cardiology capacity. - Forecast growth is tied to outpatient minimally invasive procedures, more precise energy delivery, safer temperature-controlled ablation, higher procedure volumes in emerging markets and continued electrode miniaturization. - Key trends include high-precision single-electrode ablation, greater use of internally cooled and temperature-controlled electrodes, more disposable single-use electrodes and real-time imaging-guided navigation. - RF ablation single electrode devices use controlled radiofrequency energy through one electrode to create localized thermal effects for tissue ablation. - The technology is designed to destroy or alter abnormal tissue while preserving surrounding healthy tissue. - Non-invasive cosmetic treatment demand is helping growth because RF ablation can support collagen remodeling for skin tightening and rejuvenation with minimal downtime. - The American Society of Plastic Surgeons reported in June 2024 that U.S. liposuction procedures reached 347,782 in 2023, up 7% from 2022. - The same ASPS data said minimally invasive treatments grew 7%, outpacing surgical procedures by 2 percentage points. - Chronic pain prevalence is also lifting demand because RF ablation can disrupt pain-transmitting nerves and improve mobility through minimally invasive treatment. - Arthritis Australia projected in February 2024 that osteoarthritis will affect 2.35 million Australians in 2025, or 57% of the arthritis population, and rise to 3.11 million by 2040. - Healthcare spending and infrastructure investment are supporting adoption of advanced treatments. - In January 2025, the UK Department of Health and Social Care reaffirmed plans to build 40 new hospitals by 2030 with more than $27.2 billion in infrastructure investment. - The report lists adoption in pain management, cardiac and oncological procedures as a beneficiary of improved medical infrastructure. - The report also identifies broader use of minimally invasive treatment methods as chronic disease burden rises. - The Business Research Company included contact details, sample access and a full report link, including the full market report.

Between the lines: - The forecast points to a market moving from niche procedural use toward broader routine adoption in settings that value precision, safety and lower recovery times. - Demand is being pulled by both medical necessity and elective procedures, which broadens the market base and reduces dependence on a single clinical segment. - The strongest growth theme is not just more procedures, but a shift toward devices that are easier to use, more controlled and better suited for outpatient care.

What's next: - The market outlook depends on continued expansion of outpatient care, emerging-market procedure volumes and better access to minimally invasive systems. - Product development will likely focus on smaller electrodes, better temperature control and imaging integration. - Regional growth should remain uneven, with North America retaining scale and Asia-Pacific adding momentum through higher investment and adoption. - The Business Research Company says the report will continue to track future technology and market trends through 2035.